Natural autoantibodies reactive with glycosaminoglycans in rheumatoid arthritis

Bence György, L. Tóthfalusi, György Nagy, Mária Pásztói, P. Géher, Zsolt Lörinc, Anna Polgár, Bernadett Rojkovich, I. Újfalussy, G. Poór, Péter Pócza, Zoltán Wiener, Petra Misják, A. Koncz, A. Falus, E. Búzás

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Introduction: Although natural autoantibodies make up the majority of circulating immunoglobulins and are also present in high numbers in therapeutically used intravenous immunoglobulin preparations, they have received little attention and their precise role remains largely unknown. An increasing awareness of the importance of posttranslational autoantigen modifications and glycobiology led us to explore carbohydrate-reactive natural autoantibodies in patients with rheumatoid arthritis. This study examined systematic antibodies reactive to glycosaminoglycans (GAGs), the carbohydrate components of proteoglycans that are released in large amounts from degrading cartilage. Methods: To measure antibodies reactive to six different types of GAGs, a specialised ELISA was used in which the carbohydrates were covalently linked to the plastic surface through a 2 nm spacer. Sera from rheumatoid arthritis patients (n = 66), umbilical cord serum samples (n = 11) and adult controls (n = 54) were studied. In order to explore cross-reactivity with microbial antigens, bacterial peptidoglycans and fungal polysaccharides were used. Sera and synovial fluid samples were also tested using a GlycoChip carbohydrate array to characterise individual carbohydrate recognition patterns. We followed a multistep statistical screening strategy for screening GAG-reactive antibodies as predictive disease markers. Results: While anti-GAG antibodies were absent in the umbilical cord sera, they were readily detectable in adult controls and were significantly elevated in patients with rheumatoid arthritis (p <0.001). Anti-GAG antibodies showed significant cross-reactivity among different types of GAGs. They also reacted with bacterial peptidoglycans and fungal polysaccharides. Interestingly, anti-chondroitin sulphate C IgM antibody levels showed inverse correlation both with the Disease Activity Score (DAS) 28 scores and C-reactive protein (CRP) levels in rheumatoid arthritis. Conclusion: The highly abundant and cross-reactive, GAG-specific natural autoantibodies in serum may serve as novel disease-state markers in patients with rheumatoid arthritis.

Original languageEnglish
Article numberR110
JournalArthritis Research and Therapy
Volume10
Issue number5
DOIs
Publication statusPublished - Sep 12 2008

Fingerprint

Glycosaminoglycans
Autoantibodies
Rheumatoid Arthritis
Carbohydrates
Fungal Polysaccharides
Bacterial Polysaccharides
Serum
Peptidoglycan
Antibodies
Umbilical Cord
Anti-Idiotypic Antibodies
Glycomics
Chondroitin Sulfates
Intravenous Immunoglobulins
Synovial Fluid
Autoantigens
Proteoglycans
Post Translational Protein Processing
C-Reactive Protein
Plastics

ASJC Scopus subject areas

  • Rheumatology
  • Immunology
  • Immunology and Allergy
  • Medicine(all)

Cite this

Natural autoantibodies reactive with glycosaminoglycans in rheumatoid arthritis. / György, Bence; Tóthfalusi, L.; Nagy, György; Pásztói, Mária; Géher, P.; Lörinc, Zsolt; Polgár, Anna; Rojkovich, Bernadett; Újfalussy, I.; Poór, G.; Pócza, Péter; Wiener, Zoltán; Misják, Petra; Koncz, A.; Falus, A.; Búzás, E.

In: Arthritis Research and Therapy, Vol. 10, No. 5, R110, 12.09.2008.

Research output: Contribution to journalArticle

György, Bence ; Tóthfalusi, L. ; Nagy, György ; Pásztói, Mária ; Géher, P. ; Lörinc, Zsolt ; Polgár, Anna ; Rojkovich, Bernadett ; Újfalussy, I. ; Poór, G. ; Pócza, Péter ; Wiener, Zoltán ; Misják, Petra ; Koncz, A. ; Falus, A. ; Búzás, E. / Natural autoantibodies reactive with glycosaminoglycans in rheumatoid arthritis. In: Arthritis Research and Therapy. 2008 ; Vol. 10, No. 5.
@article{e92f0e6e7949423a9a178584fb465093,
title = "Natural autoantibodies reactive with glycosaminoglycans in rheumatoid arthritis",
abstract = "Introduction: Although natural autoantibodies make up the majority of circulating immunoglobulins and are also present in high numbers in therapeutically used intravenous immunoglobulin preparations, they have received little attention and their precise role remains largely unknown. An increasing awareness of the importance of posttranslational autoantigen modifications and glycobiology led us to explore carbohydrate-reactive natural autoantibodies in patients with rheumatoid arthritis. This study examined systematic antibodies reactive to glycosaminoglycans (GAGs), the carbohydrate components of proteoglycans that are released in large amounts from degrading cartilage. Methods: To measure antibodies reactive to six different types of GAGs, a specialised ELISA was used in which the carbohydrates were covalently linked to the plastic surface through a 2 nm spacer. Sera from rheumatoid arthritis patients (n = 66), umbilical cord serum samples (n = 11) and adult controls (n = 54) were studied. In order to explore cross-reactivity with microbial antigens, bacterial peptidoglycans and fungal polysaccharides were used. Sera and synovial fluid samples were also tested using a GlycoChip carbohydrate array to characterise individual carbohydrate recognition patterns. We followed a multistep statistical screening strategy for screening GAG-reactive antibodies as predictive disease markers. Results: While anti-GAG antibodies were absent in the umbilical cord sera, they were readily detectable in adult controls and were significantly elevated in patients with rheumatoid arthritis (p <0.001). Anti-GAG antibodies showed significant cross-reactivity among different types of GAGs. They also reacted with bacterial peptidoglycans and fungal polysaccharides. Interestingly, anti-chondroitin sulphate C IgM antibody levels showed inverse correlation both with the Disease Activity Score (DAS) 28 scores and C-reactive protein (CRP) levels in rheumatoid arthritis. Conclusion: The highly abundant and cross-reactive, GAG-specific natural autoantibodies in serum may serve as novel disease-state markers in patients with rheumatoid arthritis.",
author = "Bence Gy{\"o}rgy and L. T{\'o}thfalusi and Gy{\"o}rgy Nagy and M{\'a}ria P{\'a}szt{\'o}i and P. G{\'e}her and Zsolt L{\"o}rinc and Anna Polg{\'a}r and Bernadett Rojkovich and I. {\'U}jfalussy and G. Po{\'o}r and P{\'e}ter P{\'o}cza and Zolt{\'a}n Wiener and Petra Misj{\'a}k and A. Koncz and A. Falus and E. B{\'u}z{\'a}s",
year = "2008",
month = "9",
day = "12",
doi = "10.1186/ar2507",
language = "English",
volume = "10",
journal = "Arthritis Research and Therapy",
issn = "1478-6354",
publisher = "BioMed Central",
number = "5",

}

TY - JOUR

T1 - Natural autoantibodies reactive with glycosaminoglycans in rheumatoid arthritis

AU - György, Bence

AU - Tóthfalusi, L.

AU - Nagy, György

AU - Pásztói, Mária

AU - Géher, P.

AU - Lörinc, Zsolt

AU - Polgár, Anna

AU - Rojkovich, Bernadett

AU - Újfalussy, I.

AU - Poór, G.

AU - Pócza, Péter

AU - Wiener, Zoltán

AU - Misják, Petra

AU - Koncz, A.

AU - Falus, A.

AU - Búzás, E.

PY - 2008/9/12

Y1 - 2008/9/12

N2 - Introduction: Although natural autoantibodies make up the majority of circulating immunoglobulins and are also present in high numbers in therapeutically used intravenous immunoglobulin preparations, they have received little attention and their precise role remains largely unknown. An increasing awareness of the importance of posttranslational autoantigen modifications and glycobiology led us to explore carbohydrate-reactive natural autoantibodies in patients with rheumatoid arthritis. This study examined systematic antibodies reactive to glycosaminoglycans (GAGs), the carbohydrate components of proteoglycans that are released in large amounts from degrading cartilage. Methods: To measure antibodies reactive to six different types of GAGs, a specialised ELISA was used in which the carbohydrates were covalently linked to the plastic surface through a 2 nm spacer. Sera from rheumatoid arthritis patients (n = 66), umbilical cord serum samples (n = 11) and adult controls (n = 54) were studied. In order to explore cross-reactivity with microbial antigens, bacterial peptidoglycans and fungal polysaccharides were used. Sera and synovial fluid samples were also tested using a GlycoChip carbohydrate array to characterise individual carbohydrate recognition patterns. We followed a multistep statistical screening strategy for screening GAG-reactive antibodies as predictive disease markers. Results: While anti-GAG antibodies were absent in the umbilical cord sera, they were readily detectable in adult controls and were significantly elevated in patients with rheumatoid arthritis (p <0.001). Anti-GAG antibodies showed significant cross-reactivity among different types of GAGs. They also reacted with bacterial peptidoglycans and fungal polysaccharides. Interestingly, anti-chondroitin sulphate C IgM antibody levels showed inverse correlation both with the Disease Activity Score (DAS) 28 scores and C-reactive protein (CRP) levels in rheumatoid arthritis. Conclusion: The highly abundant and cross-reactive, GAG-specific natural autoantibodies in serum may serve as novel disease-state markers in patients with rheumatoid arthritis.

AB - Introduction: Although natural autoantibodies make up the majority of circulating immunoglobulins and are also present in high numbers in therapeutically used intravenous immunoglobulin preparations, they have received little attention and their precise role remains largely unknown. An increasing awareness of the importance of posttranslational autoantigen modifications and glycobiology led us to explore carbohydrate-reactive natural autoantibodies in patients with rheumatoid arthritis. This study examined systematic antibodies reactive to glycosaminoglycans (GAGs), the carbohydrate components of proteoglycans that are released in large amounts from degrading cartilage. Methods: To measure antibodies reactive to six different types of GAGs, a specialised ELISA was used in which the carbohydrates were covalently linked to the plastic surface through a 2 nm spacer. Sera from rheumatoid arthritis patients (n = 66), umbilical cord serum samples (n = 11) and adult controls (n = 54) were studied. In order to explore cross-reactivity with microbial antigens, bacterial peptidoglycans and fungal polysaccharides were used. Sera and synovial fluid samples were also tested using a GlycoChip carbohydrate array to characterise individual carbohydrate recognition patterns. We followed a multistep statistical screening strategy for screening GAG-reactive antibodies as predictive disease markers. Results: While anti-GAG antibodies were absent in the umbilical cord sera, they were readily detectable in adult controls and were significantly elevated in patients with rheumatoid arthritis (p <0.001). Anti-GAG antibodies showed significant cross-reactivity among different types of GAGs. They also reacted with bacterial peptidoglycans and fungal polysaccharides. Interestingly, anti-chondroitin sulphate C IgM antibody levels showed inverse correlation both with the Disease Activity Score (DAS) 28 scores and C-reactive protein (CRP) levels in rheumatoid arthritis. Conclusion: The highly abundant and cross-reactive, GAG-specific natural autoantibodies in serum may serve as novel disease-state markers in patients with rheumatoid arthritis.

UR - http://www.scopus.com/inward/record.url?scp=54749117031&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54749117031&partnerID=8YFLogxK

U2 - 10.1186/ar2507

DO - 10.1186/ar2507

M3 - Article

C2 - 18789149

AN - SCOPUS:54749117031

VL - 10

JO - Arthritis Research and Therapy

JF - Arthritis Research and Therapy

SN - 1478-6354

IS - 5

M1 - R110

ER -